Literature DB >> 46267

Suppression of the immune response by alpha-fetoprotein on the primary and secondary antibody response.

R A Murgita, T B Tomasi.   

Abstract

Mouse amniotic fluid was shown to contain a noncytotoxic inhibitor of primary gammaM and secondary gammaM, gammaG subclass splenic plaque forming cells in vitro to SRBC. The suppressive effect was not abolished by exhaustive dialysis or by absorption of mouse amniotic fluid (MAF) with SRBC. Polyacrylamide gel analysis showed that dialyzed MAF was composed of three major protein components, transferrin, albumin, and alpha-fetoprotein (AFP). The selective removal of each of these patients from MAF by affinity chromatography suggested that AFP was the immunosuppressive substance in MAF. This conclusion was verified by the demonstration that pure AFP suppressed in vitro antibody synthesis in microgram quantities whereas equivalent amounts of normal mouse serum, transferrin, or albumin did not. Dose-response studies showed that the effect of AFP in the isolated form was equivalent to the suppressive effect of comparable amounts of AFP in MAF. gammaA and gammaG plaque-forming cell (PFC) responses were suppressed by a significantly lower concentration of AFP than was the gammaM PFC response. The degree of suppression watration of AFP than was the gammaM PFC response. The degree of suppression was dependent on the time at which AFP was added to the cultures; MAF added to antigen-stimulated cultures up to 24 h after initiation of cultures was immunosuppressive whereas similar additions of MAF at 48 h after initiation or later did not suppress. The duration of exposure of spleen cells to MAF in cultures without antigen necessary to achieve suppression of a subsequent primary immune response was determine-d to be approximately 8 h. The results suggest that AFP may have an immunoregulatry function. This has potentially important implications in the maternal-fetal relationship, the immune capabilities of the fetus and newborn, and in certain malignant and nonmalignant diseases in which AFP is elevated.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 46267      PMCID: PMC2190533          DOI: 10.1084/jem.141.2.269

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  53 in total

1.  Production of embryonal alpha-globulin by transplantable mouse hepatomas.

Authors:  G I ABELEV; S D PEROVA; N I KHRAMKOVA; Z A POSTNIKOVA; I S IRLIN
Journal:  Transplantation       Date:  1963-04       Impact factor: 4.939

2.  Ability of large doses of an alpha-2 plasma protein fraction to inhibit antibody production.

Authors:  J F MOWBRAY
Journal:  Immunology       Date:  1963-05       Impact factor: 7.397

3.  The effects of adrenocortical hormones, adrenocorticotrophic hormone and pregnancy on skin transplantation immunity in mice.

Authors:  P B MEDAWAR; E M SPARROW
Journal:  J Endocrinol       Date:  1956-11       Impact factor: 4.286

4.  Development of antibody-forming cells in neonatal mice: stimulation and inhibition by calf thymus fractions.

Authors:  T L Hand; W S Ceglowski; D Damrongsak; H Friedman
Journal:  J Immunol       Date:  1970-08       Impact factor: 5.422

5.  Embryonic constituents in tumors and antibodies in cancerous patients.

Authors:  P Grabar
Journal:  Curr Top Microbiol Immunol       Date:  1968       Impact factor: 4.291

6.  Quantitative estimation of antibody in the immunoglobulin classes of the mouse. II. Thymic dependence of the different classes.

Authors:  G Torrigiani
Journal:  J Immunol       Date:  1972-01       Impact factor: 5.422

7.  Selective enzyme purification by affinity chromatography.

Authors:  P Cuatrecasas; M Wilchek; C B Anfinsen
Journal:  Proc Natl Acad Sci U S A       Date:  1968-10       Impact factor: 11.205

8.  Deficient IgA antibody responses to arsanilic acid bovine serum albumin (BSA) in neonatally thymectomized rabbits.

Authors:  J D Clough; L H Mims; W Strober
Journal:  J Immunol       Date:  1971-06       Impact factor: 5.422

9.  Characteristics of antibody response in young or thymectomized mice.

Authors:  K Takeya; K Nomoto
Journal:  J Immunol       Date:  1967-10       Impact factor: 5.422

10.  Immune responses in vitro. 3. Development of primary gamma-M, gamma-G, and gamma-A plaque-forming cell responses in mouse spleen cell cultures stimulated with heterologous erythrocytes.

Authors:  C W Pierce; B M Johnson; H E Gershon; R Asofsky
Journal:  J Exp Med       Date:  1971-08-01       Impact factor: 14.307

View more
  48 in total

1.  Apoptosis-inducing protein derived from hepatocyte selectively induces apoptosis in lymphocytes.

Authors:  Masanobu Ikeda; Hideshi Yoshikawa; Jie Liu; Yasuo Nakajima; Yoshihiro Akahane; Kachio Tasaka
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

2.  Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins.

Authors:  J H Morse; L D Witte; D S Goodman
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

3.  Investigation on the inhibitory effect of tumor-derived immunosuppressive factor(s) on T lymphocyte proliferation.

Authors:  R D Wang; Z H Feng; Y Luo; Z C Chen
Journal:  J Tongji Med Univ       Date:  1989

4.  The immune response in hepatic cirrhosis: animal and human studies.

Authors:  H C Thomas
Journal:  Proc R Soc Med       Date:  1977-08

Review 5.  Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates.

Authors:  Ravid Shechter; Anat London; Michal Schwartz
Journal:  Nat Rev Immunol       Date:  2013-03       Impact factor: 53.106

6.  Feto-maternal HLA compatibility does not have a major influence on human pregnancy except for lymphocytotoxin production.

Authors:  E C Jazwinska; D C Kilpatrick; G E Smart; W A Liston
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

7.  Adult and pre-adult thymectomy of mice: contrasting effects on immune responsiveness, and on numbers of mitogen-responsive and Thy-1+ lymphocytes.

Authors:  M J Doenhoff; E Leuchars; R S Kerbel; V Wallis; A J Davies
Journal:  Immunology       Date:  1979-06       Impact factor: 7.397

8.  Rosette formation between human lymphocytes and sheep erythrocytes. Inhibition of rosette formation by specific glycopeptides.

Authors:  D H Boldt; J P Armstrong
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

9.  Localization of T and B cells and alpha fetoprotein in hepatic biopsies from patients with liver disease.

Authors:  G Husby; R G Strickland; J L Caldwell; R C Williams
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

10.  Immunosuppressive acidic protein (IAP) in gastric cancer patients.

Authors:  N Shimizu; T Yamane; T Karino; R Hamazoe; Y Osaki; H Kanayama; M Maeta; S Koga
Journal:  Jpn J Surg       Date:  1983-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.